References
- Burger P.C., Kemper L.A.K., Vogel F.S. Cancer Research 1979; 39: 1494
- Case D.E., Lindup W.E., Lowery C., Orton T.C., Reeves P.R., Whittaker S.E. British Journal of Pharmacology 1978; 63: 352P
- Dryja T.P., O'Neil-Dryja M., Pawelek J.M., Albert D.M. Investigative Ophthalmology and Visual Science 1978; 17: 511
- Friedman M.A., Woods S. Research Communications in Chemical Pathology Pharmacology 1977; 17: 623
- Lindup W.E., Longshaw S., Orton T.C., Whittaker S.E. British Journal of Pharmacology 1979; 66: 504P
- Mason C.G. Journal of Toxicology and Environmental Health 1977; 2: 977
- Nicholls J.T. Medico-Pharmaceutical Forum No. 7—Post-Marketing Surveillance of Adverse Reactions to New Medicines. Medico Pharmaceutical Forum, London 1978; 4–11
- Omura T., Sato R. Journal of Biological Chemistry 1964; 239: 2370
- Orton T.C., Lowery C. Journal of Pharmacology and Experimental Therapeutics 1981; 219: 207
- Parke D.V. Drug Toxicity, J.W. Gorrod. Taylor & Francis, London 1979; 133–150
- Poynter D., Martin L.E., Harrison C., Cook J. British Journal of Clinical Pharmacology 1976; 3(suppl.)711
- Rathbun W.B., Sethna S.S., Skelnik D.L., Bistner S.I. Experimental Eye Research 1983; 36: 845
- Reeves P.R., McCormick D.J., Jepson H.T. Xenobiotica 1979; 9: 453
- Rosenbaum S.E., Lindup W.E., Orton T.C. Journal of Pharmacology and Experimental Therapeutics 1985; 234: 485
- Saneto R.P., Awasthi Y.C., Srivastava S.K. Biochemical Journal 1982; 205: 213
- Scales B., Cosgrove M.B. Journal of Pharmacology and Experimental Therapeutics 1970; 175: 338
- Shichi H., Atlas S.A., Nebert D.W. Experimental Eye Research 1975; 21: 557
- Shichi H., Gaasterland D.E., Jensen N.M., Nebert D.W. Science 1978; 200: 539
- Shichi H., Tanaka M., Jensen N.M., Nebert D.W. Pharmacology 1980; 20: 229
- Vogel S.F., Kemfer L.A.K., Boekelheiue K., Graham D.G., Jeffs P.W. Cancer Research 1979; 39: 1490
- Zampaglione N.G., Jollow D.J., Mitchell J.R., Stripf B., Hamrick M., Gillette J.R. Journal of Pharmacology and Experimental Therapeutics 1973; 187: 218